Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 0.9800
-0.0250 (-2.49%)
Nov 3, 2026, 4:08 PM HKT
Brii Biosciences Employees
Brii Biosciences had 80 employees as of June 30, 2026. The number of employees increased by 5 or 6.67% since the number was reported on December 31, 2025. That makes Brii Biosciences the 32,755th largest employer in the world and 2,100th in Hong Kong.
Employees
80
Change
5
Growth
6.67%
Revenue / Employee
502.93K HKD
Profits / Employee
-2.53M HKD
Market Cap
707.42M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 80 | 5 | 6.67% |
| Dec 31, 2025 | 75 | -23 | -23.47% |
| Dec 31, 2024 | 98 | -30 | -23.44% |
| Dec 31, 2023 | 128 | -18 | -12.33% |
| Dec 31, 2022 | 146 | 33 | 29.20% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,787 |
| JW (Cayman) Therapeutics Co. | 303 |
| Zhaoke Ophthalmology | 285 |
| TYK Medicines | 184 |
| 3D Medicines | 162 |
| Sunho Biologics | 128 |
| Kintor Pharmaceutical | 122 |
| Wuhan YZY Biopharma | 68 |
Brii Biosciences News
- 18 days ago - Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform - PRNewsWire
- 2 months ago - Brii Biosciences Earnings release: H1 2026 - Filings
- 2 months ago - Brii Biosciences Quarterly report: H1 2026 - Filings
- 5 months ago - Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV - PRNewsWire
- 6 months ago - Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026 - PRNewsWire
- 7 months ago - Brii Biosciences Earnings Call Transcript: H2 2025 - Transcripts
- 7 months ago - Brii Biosciences Earnings release: H2 2025 - Filings
- 7 months ago - Brii Biosciences Annual report: H2 2025 - Filings